-
Quetiapine Outperforms Lithium in Resistant Depression
11 Apr 2025 12:26 GMT
… week trial among adults with treatment-resistant depression, quetiapine … of the two drugs was compared from … medication discontinuation was comparable between the two groups (P =.1196).
The quetiapine … various ties with pharmaceutical companies and research …
-
Sad descent into drugs hell of high-flying model Savannah McKay, who partied with Hollywood's finest
09 Apr 2025 12:30 GMT
… photo shoots before her drug habit derailed her promising … drugs 1,4 butanediol and GHB and quetiapine - a schizophrenia medication … and party drugs 1,4 butanediol and GHB and quetiapine
Savannah … photo shoots before her drug habit derailed her promising …
-
Comprehensive Description of an Automated Drug Dispensing System Database
08 Apr 2025 07:25 GMT
… for it from a medical doctor and takes at least … be prescribed by a medical doctor.2 Drugs can then - depending … high quality. Pharmacists or pharmaceutical technicians enter patient data into … : the irrational case of Quetiapine. Biomed Res Int. 2015 …
-
Xanomeline and Trospium Chloride Versus Placebo for the Treatment of Schizophrenia: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed
05 Apr 2025 08:44 GMT
… Drug Administration (FDA) awarded xanomeline/trospium approval for the treatment … olanzapine, paliperidone, quetiapine, risperidone, and … Trial Design
The pivotal EMERGENT-1, EMERGENT-2, and EMERGENT-3 trials … and Takeda Pharmaceuticals. The authors …
-
Quetiapine bests Lithium for Treatment-Resistant Depression, finds research
04 Apr 2025 16:01 GMT
… trial that quetiapine was more effective than lithium for augmenting treatment-resistant depression. Quetiapine … two or more therapeutic antidepressant trials. Exclusion criteria included … care before proceeding to trial medication initiation. The coprimary …
-
Top 5 FDA Approvals from Q1 2025
01 Apr 2025 16:14 GMT
… Drug Administration (FDA) approved a wave of transformative therapies that redefined treatment … Amvuttra)
Developer: Alnylam Pharmaceuticals
Approval Date: March … and active-controlled trials in patients … oral antidepressants.
Read about more FDA approvals …
-
Use of Long-Acting Injectable Antipsychotic Medications in Schizophrenia Treatment
01 Apr 2025 15:14 GMT
… Medicine)
Pimavanserin (for psychosis due to Parkinson disease) (Nuplazid; Acadia Pharmaceuticals)
Quetiapine … of relapses.
Unlike the oral pill burden, LAIs can be … -announcements/fda-approves-drug-new-mechanism-action-treatment-schizophrenia?os=wtmb …
-
Dementia Associated With Alzheimer’S Disease Clinical Trials And Studies 2025: EMA, PDMA, FDA Approvals, Mechanism Of Action, ROA, NDA, IND, And Companies
27 Mar 2025 01:06 GMT
… .S. Food and Drug Administration (FDA) has closed the … Eisai Inc., Shanghai Hengrui Pharmaceutical Co., Ltd and others.
… drug is in Phase III stage of its clinical trial for the treatment … ITI-1284, Brexpiprazole, KarXT, Quetiapine Fumarate, DMB-I (Dimebon), …
-
Bausch: Potential Breakthrough in Depression Treatment to Unlock $3B Opportunity?
21 Mar 2025 09:57 GMT
… , pharmaceutical companies have introduced several blockbuster medications, … Treatment-Resistant Depression: A Profound Unmet Medical) Need
Despite their widespread use, antidepressant medications … S. Food and Drug Administration (FDA) approved Spravato ( …
-
Affordable healthcare: Koko Pimentel hails VAT-free move on 17 medicines
21 Mar 2025 10:39 GMT
… and Drug Administration (FDA) in getting 17 medicine products … The FDA said these new VAT-free medicines include treatments for … , and sertraline and quetiapine for mental health conditions … people,” said Pimentel.
“Medicine should be accessible and …
About
© 1995-2025